{"id":{"repo_id":"bu","oai_identifier":"oai:open.bu.edu:2144/53142"},"canonical_url":"https://search.ndltd.org/etd/bu/oai:open.bu.edu:2144/53142","repository":{"repo_id":"bu","name":"Boston University","base_url":"https://open.bu.edu/oai/request"},"display":{"title":"Endothelial GATA6 deficiency suppresses intracellular TLR3-interferon signaling in HPAECs and promotes interferon response in HPASMCs","abstract":"GATA6 is a key transcription factor crucial for maintaining endothelial cell (EC) homeostasis. The dysregulation of endothelial immune function is a central feature in diseases such as pulmonary arterial hypertension (PAH). In this study, we explored the consequences of GATA6 deficiency in human pulmonary arterial endothelial cells (HPAECs) and its impact on immune response pathways. We report that siRNA-induced GATA6 deficiency or the GATA inhibitor led to significant downregulation of interferon response genes and a marked reduction in toll-like receptor 3 (TLR3) expression. GATA6 overexpression enhanced the expression of these genes, and TLR3 inhibition abrogated this response. Furthermore, conditioned medium from GATA6-deficient HPAECs upregulated interferon genes in pulmonary smooth muscle cells (HPASMCs), indicating a paracrine effect. Transcriptomic and miRNA profiling of exosomes isolated from conditioned medium of GATA6 deficient HPAECs further revealed that GATA6 deficiency alters the endothelial miRNA landscape, targeting key innate immune and inflammatory pathways including targets on TLR3 and TGF-β signaling pathway. Overall, these findings highlight the critical role of GATA6 in modulating TLR3 signaling and immune responses in endothelial cells and suggest its involvement in endothelial-smooth muscle cell interactions in vascular inflammation","abstract_html":"GATA6 is a key transcription factor crucial for maintaining endothelial cell (EC) homeostasis. The dysregulation of endothelial immune function is a central feature in diseases such as pulmonary arterial hypertension (PAH). In this study, we explored the consequences of GATA6 deficiency in human pulmonary arterial endothelial cells (HPAECs) and its impact on immune response pathways. We report that siRNA-induced GATA6 deficiency or the GATA inhibitor led to significant downregulation of interferon response genes and a marked reduction in toll-like receptor 3 (TLR3) expression. GATA6 overexpression enhanced the expression of these genes, and TLR3 inhibition abrogated this response. Furthermore, conditioned medium from GATA6-deficient HPAECs upregulated interferon genes in pulmonary smooth muscle cells (HPASMCs), indicating a paracrine effect. Transcriptomic and miRNA profiling of exosomes isolated from conditioned medium of GATA6 deficient HPAECs further revealed that GATA6 deficiency alters the endothelial miRNA landscape, targeting key innate immune and inflammatory pathways including targets on TLR3 and TGF-β signaling pathway. Overall, these findings highlight the critical role of GATA6 in modulating TLR3 signaling and immune responses in endothelial cells and suggest its involvement in endothelial-smooth muscle cell interactions in vascular inflammation","abstract_has_math":false,"creators":["Dambal, Vrinda Y."],"institution":"Boston University","degree_name":"Doctor of Philosophy","degree_level":"doctoral","degree_discipline":"Molecular and Translational Medicine","degree_department":null,"school":null,"contributors":[],"advisors":["Seta, Francesca"],"committee_chairs":[],"committee_members":[],"year":2025,"date_issued":"2025","date_published":"2025","updated_at":"2026-11-19T02:42:12Z","subjects":["Molecular biology","Cellular biology","Endothelial cell biology","Pulmonary arterial hypertension","Pulmonary artertial endothelial cellss","Pulmonary artery smooth muscle cells","TLR3 signaling"],"languages":["en_US"],"rights":[],"rights_urls":[],"identifier_entries":[],"person_identifier_entries":[{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0002-5843-6523"],"render_values":[{"text":"0000-0002-5843-6523","href":"https://orcid.org/0000-0002-5843-6523","code":true}]}]},"links":{"outbound_url":"https://hdl.handle.net/2144/53142","outbound_label":"Handle","outbound_source":"dc:identifier.uri","record_url":"https://hdl.handle.net/2144/53142","record_label":"Repository record","record_kind":"handle","record_source":"dc:identifier.uri","download_url":null,"download_label":null,"download_source":null,"access_status":null,"embargo_until":null,"access_note":null},"source_record":{"url":"https://open.bu.edu/oai/request?verb=GetRecord&metadataPrefix=dim&identifier=oai%3Aopen.bu.edu%3A2144%2F53142","prefix":"dim"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor.advisor","label":"Advisor","values":["Seta, Francesca"]},{"key":"dc:creator","label":"Author","values":["Dambal, Vrinda Y."]},{"key":"dc:identifier.orcid","label":"ORCID","values":["0000-0002-5843-6523"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date.accessioned","label":"Dc Date Accessioned","values":["2026-06-16T15:00:02Z"]},{"key":"dc:date.embargo","label":"Dc Date Embargo","values":["2027-06-15T00:00:00Z"]},{"key":"dc:date.issued","label":"Date","values":["2025"]},{"key":"dc:date.updated","label":"Dc Date Updated","values":["2026-06-15T22:10:55Z"]},{"key":"dc:type","label":"Dc Type","values":["Thesis/Dissertation"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Molecular and Translational Medicine"]},{"key":"thesis:degree_level","label":"Degree Level","values":["doctoral"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Doctor of Philosophy"]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["Boston University"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Molecular biology","Cellular biology","Endothelial cell biology","Pulmonary arterial hypertension","Pulmonary artertial endothelial cellss","Pulmonary artery smooth muscle cells","TLR3 signaling"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language.iso","label":"Language (ISO)","values":["en_US"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier.uri","label":"Identifier URI","values":["https://hdl.handle.net/2144/53142"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["2025"]},{"key":"dc:description.abstract","label":"Abstract","values":["GATA6 is a key transcription factor crucial for maintaining endothelial cell (EC) homeostasis. The dysregulation of endothelial immune function is a central feature in diseases such as pulmonary arterial hypertension (PAH). In this study, we explored the consequences of GATA6 deficiency in human pulmonary arterial endothelial cells (HPAECs) and its impact on immune response pathways. We report that siRNA-induced GATA6 deficiency or the GATA inhibitor led to significant downregulation of interferon response genes and a marked reduction in toll-like receptor 3 (TLR3) expression. GATA6 overexpression enhanced the expression of these genes, and TLR3 inhibition abrogated this response. Furthermore, conditioned medium from GATA6-deficient HPAECs upregulated interferon genes in pulmonary smooth muscle cells (HPASMCs), indicating a paracrine effect. Transcriptomic and miRNA profiling of exosomes isolated from conditioned medium of GATA6 deficient HPAECs further revealed that GATA6 deficiency alters the endothelial miRNA landscape, targeting key innate immune and inflammatory pathways including targets on TLR3 and TGF-β signaling pathway. Overall, these findings highlight the critical role of GATA6 in modulating TLR3 signaling and immune responses in endothelial cells and suggest its involvement in endothelial-smooth muscle cell interactions in vascular inflammation"]},{"key":"dc:title","label":"Title","values":["Endothelial GATA6 deficiency suppresses intracellular TLR3-interferon signaling in HPAECs and promotes interferon response in HPASMCs"]}]}],"canonical_facts":{"dc:contributor.advisor":["Seta, Francesca"],"dc:creator":["Dambal, Vrinda Y."],"dc:date.accessioned":["2026-06-16T15:00:02Z"],"dc:date.embargo":["2027-06-15T00:00:00Z"],"dc:date.issued":["2025"],"dc:date.updated":["2026-06-15T22:10:55Z"],"dc:description":["2025"],"dc:description.abstract":["GATA6 is a key transcription factor crucial for maintaining endothelial cell (EC) homeostasis. The dysregulation of endothelial immune function is a central feature in diseases such as pulmonary arterial hypertension (PAH). In this study, we explored the consequences of GATA6 deficiency in human pulmonary arterial endothelial cells (HPAECs) and its impact on immune response pathways. We report that siRNA-induced GATA6 deficiency or the GATA inhibitor led to significant downregulation of interferon response genes and a marked reduction in toll-like receptor 3 (TLR3) expression. GATA6 overexpression enhanced the expression of these genes, and TLR3 inhibition abrogated this response. Furthermore, conditioned medium from GATA6-deficient HPAECs upregulated interferon genes in pulmonary smooth muscle cells (HPASMCs), indicating a paracrine effect. Transcriptomic and miRNA profiling of exosomes isolated from conditioned medium of GATA6 deficient HPAECs further revealed that GATA6 deficiency alters the endothelial miRNA landscape, targeting key innate immune and inflammatory pathways including targets on TLR3 and TGF-β signaling pathway. Overall, these findings highlight the critical role of GATA6 in modulating TLR3 signaling and immune responses in endothelial cells and suggest its involvement in endothelial-smooth muscle cell interactions in vascular inflammation"],"dc:identifier.orcid":["0000-0002-5843-6523"],"dc:identifier.uri":["https://hdl.handle.net/2144/53142"],"dc:language.iso":["en_US"],"dc:subject":["Molecular biology","Cellular biology","Endothelial cell biology","Pulmonary arterial hypertension","Pulmonary artertial endothelial cellss","Pulmonary artery smooth muscle cells","TLR3 signaling"],"dc:title":["Endothelial GATA6 deficiency suppresses intracellular TLR3-interferon signaling in HPAECs and promotes interferon response in HPASMCs"],"dc:type":["Thesis/Dissertation"],"thesis:degree_discipline":["Molecular and Translational Medicine"],"thesis:degree_level":["doctoral"],"thesis:degree_name":["Doctor of Philosophy"],"thesis:institution_name":["Boston University"]},"updated_at":"2026-11-19T02:42:12Z"}